A detailed history of Ballentine Partners, LLC transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 1,440 shares of IQV stock, worth $341,049. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,440
Previous 1,424 1.12%
Holding current value
$341,049
Previous $360,000 15.56%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$211.18 - $248.87 $3,378 - $3,981
16 Added 1.12%
1,440 $304,000
Q1 2024

Apr 11, 2024

BUY
$208.23 - $259.1 $31,234 - $38,865
150 Added 11.77%
1,424 $360,000
Q4 2023

Jan 23, 2024

SELL
$177.16 - $232.73 $293,554 - $385,633
-1,657 Reduced 56.53%
1,274 $294,000
Q3 2023

Oct 19, 2023

SELL
$196.75 - $231.96 $52,925 - $62,397
-269 Reduced 8.41%
2,931 $576,000
Q2 2023

Jul 26, 2023

BUY
$183.66 - $224.77 $384,951 - $471,117
2,096 Added 189.86%
3,200 $719,000
Q1 2023

Apr 27, 2023

BUY
$188.0 - $240.65 $207,552 - $265,677
1,104 New
1,104 $219,000

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $44B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.